Long-term indoramin therapy in congestive heart failure: A double-blind, randomized, parallel placebo-controlled trial
Authors:
- Carl V. LeierCLCarl V. Leier
- Philip F. BinkleyPBPhilip F. Binkley
- Patricia Huss RandolphPRPatricia Huss Randolph
- Donald V. UnverferthDUDonald V. Unverferth
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Indoramin‐prolongation of repolarization time, a mechanism of bradycardia in man?British Journal of Clinical Pharmacology, 1985
- The cardiovascular effects of centrally and peripherally administered indoramin in conscious ratsEuropean Journal of Pharmacology, 1985
- Electrophysiological Effects of α-Adrenoceptor Stimulation in Normal and Ischemic MyocardiumJournal of Cardiovascular Pharmacology, 1985
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Differential blockade of alpha‐adrenoceptors by indoramin.British Journal of Clinical Pharmacology, 1984
- Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failureThe American Journal of Cardiology, 1982
- Plasma norepinephrine in congestive heart failureThe American Journal of Cardiology, 1978
- Central and peripheral contribution to the antihypertensive action of indoraminEuropean Journal of Pharmacology, 1975
- The reversal of experimental cardiac arrhythmias by indoramin (Wy 21901)Journal of Pharmacy and Pharmacology, 1971
- Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failureThe American Journal of Medicine, 1965